“Pivotal repeated dose toxicity studies include studies in rats and cynomolgus monkeys with treatment durations, in both animal species, of 4, 13 and 26 weeks.”
Monkey: similar in vitro metabolic stability and protein binding to human; predictive of echinocandin toxicity in humans
“Cynomolgus monkeys were chosen as the nonrodent toxicology species due to similar in vitro metabolic stability and protein binding characteristics to humans and because monkeys have been shown to be predictive for echinocandin-induced toxicity in humans.”